Alina Basnet | Oncology | Best Researcher Award

Posted on by ScienceFather

Dr. Alina Basnet | Oncology | Best Researcher Award

Associate Professor of Medicine, SUNY Upstate Medical University, United States

Profile

Scopus

Short Bio

Dr. Alina Basnet is an accomplished Assistant Professor of Medicine at SUNY Upstate Medical University in the Division of Hematology Oncology. She is a dedicated clinician and educator with extensive experience in internal medicine and oncology, contributing significantly to the field through her clinical practice, research, and teaching.

Education 🎓

Dr. Basnet earned her Bachelor of Medicine and Bachelor of Surgery (MBBS) from Kathmandu University, Nepal (2003-2009). Prior to medical school, she completed her higher secondary degree at St. Xavier’s Campus, Tribhuvan University, Nepal (2001-2003). Her postgraduate training includes an Internal Medicine Residency at Seton Hall University (2012-2015) and a Hematology-Oncology Fellowship at SUNY Upstate Medical University (2015-2018).

Experience 💼

Dr. Basnet serves as the Fellowship Program Director for the Division of Hematology Oncology at SUNY Upstate Medical University since June 2023. She has also been a Clinical Assistant Professor in the Department of Internal Medicine since 2018. Previously, she was the Quality Officer for the division and has held various clinical and academic positions in Nepal and the United States.

Research Interests 🔬

Dr. Basnet’s research focuses on genitourinary cancers, clinical outcomes in oncology, and the role of tumor mutational burden in therapeutic response. She has been a principal investigator in several clinical trials and actively collaborates with national cooperative oncology groups.

Awards and Honors 🏆

Dr. Basnet has been recognized with several awards, including the Intern of the Year (2012-2013) and travel awards to major conferences like ASCO and the Hematology Fellows Consortium. She also received invitations to present at regional and national oncology meetings.

Publications 📚

  1. Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma with Elevated Tumor Mutational Burden
    • Necchi A, Spiess PE, Costa de Padua T, Li R, Grivas P, Huang RSP, Lin DI, Danziger N, Ross JS, Jacob JM, Sager RA, Basnet A, et al.
    • JAMA Netw Open (2023), cited by 38 articles.
  2. PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients with High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer
    • Aggarwal R, Heller G, Hillman DW, Xiao H, Picus J, Taplin ME, Dorff T, Appleman L, Weckstein D, Patnaik A, Basnet A, et al.
    • J Clin Oncol (2024), cited by 12 articles.

Julio Pimente | Cancer Biology | Young Scientist Award

Posted on by ScienceFatherLeave a Comment on Julio Pimente | Cancer Biology | Young Scientist Award

Dr. Julio Pimente | Cancer Biology | Young Scientist Award

Dr. Julio M. Pimentel is an accomplished cancer biologist and clinical researcher specializing in translational medicine. With a robust background in studying resistance mechanisms in cancer therapies, Dr. Pimentel has significantly contributed to understanding and overcoming resistance in triple-negative breast cancer (TNBC) and pancreatic cancer. Currently, he serves as an Institutional Research Academic Career Development Award (IRACDA) Postdoctoral Fellow at the University of California, San Diego. His work is aimed at improving cancer treatment outcomes and expanding leadership diversity in STEM fields.

Profile 📄

For more details on Dr. Julio M. Pimentel’s academic and professional journey, visit his LinkedIn profile.

Education 🎓

Doctor of Philosophy in Cancer Biology (2023), Wayne State University School of Medicine. Dissertation: “The Mechanisms of TRAIL Resistance in Triple-Negative Breast Cancer.”

Master of Science in Clinical Investigation and Translational Medicine (2018), University of Miami Miller School of Medicine. Thesis: “Metabolic Reprogramming with Beta-Alanine to Overcome Gemcitabine Resistance in Pancreatic Cancer.”

Bachelor of Science in Biological Sciences (2014), California State University Stanislaus, with concentrations in Molecular Biology & Microbiology and a Minor in Chemistry.

Experience 🧑‍🔬

IRACDA Postdoctoral Fellow (2023-Present), University of California San Diego. Research on endothelial cytoprotective signaling.

Ph.D. Graduate Research Assistant (2019-2023), Barbara Ann Karmanos Institute & Wayne State University. Investigated mechanisms of TRAIL resistance in TNBC.

MSCTI Graduate Research Assistant (2016-2018), University of Miami & Sylvester Comprehensive Cancer Center. Focused on overcoming chemoresistance in pancreatic cancer.

Instructional Student Assistant (2012-2016), California State University Stanislaus. Tutored students in various scientific disciplines.

Licensed Nurse Aide (2012-2013), Covenant Care at Home & Emanuel Medical Center. Provided end-of-life care.

Research Interests 🔬

Dr. Pimentel’s research interests include cancer biology, mechanisms of drug resistance, translational medicine, and immunotherapy. His work primarily focuses on identifying and targeting resistance pathways in aggressive cancers, such as TNBC and pancreatic cancer, to improve therapeutic efficacy and patient outcomes.

Awards 🏆

UCSD Institutional Research Academic Career Development Award (2025-2023)

Leonard N. Simons Award (2023)

Oakland County Executive’s Oakland Together 40 Under 40 Class of 2023

Top 100 Innovators and Entrepreneurs by The Top 100 Magazine (2022)

National Latino Leader Award by the National Diversity Council (2021)

Publications Top Notes 📚

Targeting PP2A to Overcome TRAIL Resistance in TNBC Cells (Published in Journal of Cancer Research, 2023) [Cited by 25 articles].

p62/SQSTM1 as a Critical Player in PARP Inhibitor Resistance in Triple-Negative Breast Cancer (Published in Molecular Carcinogenesis, 2022) [Cited by 18 articles].

RNA-seq Identifies Inflammatory Pathways to Confer TRAIL Resistance in TNBC Cells (Under Peer Review, 2023).